Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 14/20 | 0.94 |
| ▸ | TAS1R1 | Q7RTX1 | 13/20 | 0.94 |
| ▸ | TAS1R2 | Q8TE23 | 12/20 | 0.94 |
| ▸ | MLYCD | O95822 | 1/20 | 0.59 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL701892 | 0.97 | TAS1R3 (1.00) | TAS1R3TAS1R1TAS1R2MLYCDSSTR3 | |
| SCHEMBL13304423 | 0.85 | TAS1R3 (0.70) | TAS1R3TAS1R1TAS1R2MLYCDSSTR3 | |
| SCHEMBL3143959 | 0.85 | TAS1R3 (0.70) | TAS1R3TAS1R1TAS1R2MLYCDNPC1 | |
| SCHEMBL702461 | 0.85 | TAS1R3 (1.00) | TAS1R3TAS1R1TAS1R2MLYCDSSTR3 | |
| SCHEMBL5752639 | 0.83 | TAS1R3 (1.00) | TAS1R3TAS1R1TAS1R2MLYCD | |
| SCHEMBL3144860 | 0.83 | TAS1R3 (0.74) | TAS1R3TAS1R1TAS1R2MLYCDRAB9A | |
| SCHEMBL13304428 | 0.83 | TAS1R3 (0.74) | TAS1R3TAS1R1TAS1R2MLYCDNPC1 | |
| SCHEMBL517994 | 0.81 | MLYCD (0.77) | TAS1R3TAS1R1TAS1R2MLYCD | |
| SCHEMBL517318 | 0.81 | TAS1R3 (0.72) | TAS1R3TAS1R1TAS1R2MLYCD | |
| SCHEMBL3132140 | 0.81 | TAS1R3 (0.64) | TAS1R3TAS1R1TAS1R2MLYCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101351442-B | Amide compound and use thereof | SUMITOMO CHEMICAL CO.,LTD. (JP) | 2011-12-14 | — | — | CN | disclosed |
| US-7902400-B2 | N-(1,1-diemthylpropyl)-4-(2-propynyloxy)-3-methoxybenzamide; N-(2,2-diemthylpropyl)-4-(2-propynyloxy)-3-methoxybenzamide; controlling plant diseases | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-03-08 | — | — | US | disclosed |
| US-20090131531-A1 | Amide Compounds and their Use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-05-21 | — | — | US | disclosed |
| CN-101351442-A | Amide compound and use thereof | SUMITOMO CHEMICAL CO (JP) | 2009-01-21 | — | — | CN | disclosed |
| EP-1940780-A1 | AMIDE COMPOUNDS AND THEIR USE | SUMITOMO CHEMICAL CO., LTD. (JP) | 2008-07-09 | — | — | EP | disclosed |
| WO-2007049728-A1 | AMIDE COMPOUNDS AND THEIR USE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-05-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131531-A1 | Amide Compounds and their Use | NAT1, ACAT2, NAAA | TAS1R3 1939/4885TAS1R1 885/4885TAS1R2 1150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.